These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 7697902

  • 1. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ, Agrawal NM.
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [Abstract] [Full Text] [Related]

  • 2. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R, Caselli M, Castellino G, Bajocchi G, Trotta F.
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 4. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 5. Prevention of NSAID-gastropathy.
    Ardizzone S, Bianchi Porro G.
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [Abstract] [Full Text] [Related]

  • 6. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A, Wells G, Tugwell P, Welch V, Dube C, McGowan J.
    Cochrane Database Syst Rev; 2000 Dec; (4):CD002296. PubMed ID: 11034748
    [Abstract] [Full Text] [Related]

  • 7. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J.
    Cochrane Database Syst Rev; 2002 Dec; (4):CD002296. PubMed ID: 12519573
    [Abstract] [Full Text] [Related]

  • 8. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM, Bytzer P.
    Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151
    [Abstract] [Full Text] [Related]

  • 9. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY.
    Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000
    [Abstract] [Full Text] [Related]

  • 10. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar 08; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 11. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS, Beglinger C.
    Schweiz Med Wochenschr; 1999 Jul 27; 129(29-30):1073-80. PubMed ID: 10464910
    [Abstract] [Full Text] [Related]

  • 12. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM, Dajani EZ.
    J Assoc Acad Minor Phys; 1992 Jul 27; 3(4):142-8. PubMed ID: 1392409
    [Abstract] [Full Text] [Related]

  • 13. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy.
    Graham DY.
    Gastroenterology; 1989 Feb 27; 96(2 Pt 2 Suppl):675-81. PubMed ID: 2642452
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract.
    Agrawal NM.
    Br J Rheumatol; 1995 Apr 27; 34 Suppl 1():5-10. PubMed ID: 7780679
    [Abstract] [Full Text] [Related]

  • 15. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment.
    Zfass AM, McHenry L, Sanyal AJ.
    Gastroenterologist; 1993 Jun 27; 1(2):165-9. PubMed ID: 8049889
    [Abstract] [Full Text] [Related]

  • 16. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage.
    Valentini M, Cannizzaro R, Poletti M, Bortolussi R, Fracasso A, Testa V, Sozzi M, Fornasarig M, Bortoluzzi F, Grazioli I.
    J Clin Oncol; 1995 Oct 27; 13(10):2637-42. PubMed ID: 7595718
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM.
    Eur J Rheumatol Inflamm; 1993 Oct 27; 13(1):17-24. PubMed ID: 7821335
    [Abstract] [Full Text] [Related]

  • 18. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM, Dajani EZ.
    J Rheumatol Suppl; 1990 Feb 27; 20():7-11. PubMed ID: 1969964
    [Abstract] [Full Text] [Related]

  • 19. Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists.
    Koch M, Capurso L, Dezi A, Ferrario F, Scarpignato C.
    Dig Dis; 1995 Jan 27; 13 Suppl 1():62-74. PubMed ID: 7697903
    [Abstract] [Full Text] [Related]

  • 20. Treatment of nonsteroidal anti-inflammatory drug-associated gastric and duodenal damage. Efficacy of antisecretory drugs and mucosal protective compounds.
    Pipkin G, Mills JG.
    Dig Dis; 1995 Jan 27; 13 Suppl 1():75-88. PubMed ID: 7697904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.